Turkey To Produce Cancer Drugs Locally, But Looks To Big Pharma To Invest In Infrastructure
This article was originally published in PharmAsia News
Executive Summary
As access to cancer drugs become a wider problem, Turkey moves to produce needed generics locally, as the country looks to Big Pharma to invest in the country’s infrastructure.